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Abstract
Background: A healthy immune system requires immune cells that adapt rapidly to environmental challenges.
This phenotypic plasticity can be mediated by transcriptional and epigenetic variability.
Results: We apply a novel analytical approach to measure and compare transcriptional and epigenetic variability
genome-wide across CD14+CD16− monocytes, CD66b+CD16+ neutrophils, and CD4+CD45RA+ naïve T cells from the
same 125 healthy individuals. We discover substantially increased variability in neutrophils compared to monocytes and
T cells. In neutrophils, genes with hypervariable expression are found to be implicated in key immune pathways and are
associated with cellular properties and environmental exposure. We also observe increased sex-specific gene expression
differences in neutrophils. Neutrophil-specific DNA methylation hypervariable sites are enriched at dynamic chromatin
regions and active enhancers.
Conclusions: Our data highlight the importance of transcriptional and epigenetic variability for the key role of
neutrophils as the first responders to inflammatory stimuli. We provide a resource to enable further functional studies into
the plasticity of immune cells, which can be accessed from: http://blueprint-dev.bioinfo.cnio.es/WP10/hypervariability.
Keywords: Differential variability, Phenotypic plasticity, Heterogeneity, Immune cells, Monocytes, Neutrophils,
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Background
Phenotypic plasticity is fundamental to human immunity,
allowing rapid cellular adaptation in response to changing
environmental conditions [1]. Plasticity of immune cells
can be influenced by the variability of cellular traits,
including gene expression and DNA methylation. The
stochastic nature inherent to cellular processes such as
gene regulation gives rise to cell-to-cell variation, en-
hancing survival under adverse conditions and stress
[2–4]. Environmental stimuli, including temperature,
hormone levels, and invading pathogens, further affect
the expression of genes in a tissue- and temporal-
dependent fashion [2, 4, 5].
Rapid and effective response to a stimulus is facilitated
and intensified if the cellular trait already exhibits large
stochastic fluctuations in the absence of the stimulus [3].
For example, while genes involved in stress response
tend to be highly variable [3, 6, 7], genes involved in
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essential cellular functions, such as protein synthesis and
metabolism, demonstrate less variable expression levels
[8, 9].
B and T cells utilize genetic recombination to gener-
ate a highly diverse repertoire of immunoglobulins and
T-cell surface receptors, respectively. In addition, immune
responses are driven by the variability of key signaling
molecules and transcription factors not controlled by gen-
etic factors [10, 11]. Epigenetic states, including DNA
methylation, also contribute to plastic gene expression
during cell fate commitment, thus enhancing fitness in re-
sponse to external cues [12, 13].
Transcriptional and epigenetic heterogeneity that is
measured across individuals emerges from different ori-
gins. While intra-individual variability can relate to differ-
ent cellular properties in response to external signals, such
as cell activation and communication [3, 7, 14], inter-
individual variability can relate to differences between the
individuals, including genetic makeup, age, sex, and life-
style. Importantly, it has also been demonstrated that
inter-individual variability can serve as an appropriate
proxy for intra-individual variability at the level of single
cells [7, 14, 15].
Both transcriptional and epigenetic variability have
been shown to strongly correlate with the develop-
ment and progression of human diseases [12, 16, 17].
For example, gene expression variability has been
linked to human immunodeficiency virus (HIV) sus-
ceptibility [18], neurological disorders [18, 19], and
cancer [20, 21]. Hypervariable DNA methylation loci
can be used as biomarkers to predict the risk of neoplastic
transformation in stages prior to neoplasia [22, 23].
The extent and functional interpretation of tran-
scriptional and epigenetic variability have not been sys-
tematically investigated genome-wide across multiple
immune cell types in the general population. Here, we
applied a novel analytical approach to measure differ-
ential variability of gene expression and DNA methyla-
tion in three major immune cell types: CD14+CD16−
classic monocytes, CD66b+CD16+ neutrophils, and
CD4+CD45RA+ “phenotypically naïve” T cells. This
matched panel of cell types was derived from the same
125 healthy individuals. We show that neutrophils ex-
hibit substantially increased variability of both gene
expression and DNA methylation patterns, compared
to monocytes and T cells, consistent with these cells’
key role as the first line of host defense. We annotated
hypervariable genes (HVGs) and CpGs (HVPs) to
known homeostatic and pathogenic immune processes
and found subsets of genes correlating with genetic
makeup, donor demographic, and lifestyle factors. Our
data further reveal potential molecular mechanisms of
immune responses to environmental stimuli and pro-
vide a resource to enable future functional studies into
the phenotypic plasticity of human immune cells in
health and disease.
Results
Deep molecular profiling of immune cells in the
BLUEPRINT Human Variation Panel
The analyses described in this study are based on the
publicly available resource provided by the BLUEPRINT
Human Variation Panel [24]. The resource contains gen-
ome-wide molecular profiles of CD14+CD16− classic
monocytes, CD66b+CD16+ neutrophils, and CD4
+CD45RA+ naïve T cells. These leukocyte types were
chosen due to their important role in mediating im-
mune cell processes, their relative abundance in periph-
eral blood, allowing for examination of multiple cellular
traits, as well as the availability of experimental proto-
cols to prepare cell populations of high purity (>95%).
Monocytes and neutrophils are myeloid cells that share
the same bone marrow-residing granulocyte-macrophage
precursor cell. Monocytes migrate to sites of infection and
differentiate into macrophages and dendritic cells to in-
duce an immune response. As part of the innate immune
system, neutrophils move within minutes to sites of infec-
tion during the acute phase of inflammation. Naïve T cells
are lymphoid cells that are part of the adaptive immune
system, representing mature helper T cells that have not
yet recognized their cognate antigen.
Across an initial cohort of 200 healthy individuals
representative of the UK population, purified prepara-
tions of these primary cells were probed for gene ex-
pression using total RNA sequencing (RNA-seq) and
DNA methylation using Illumina Infinium Human-
Methylation450 BeadChips (“450 K arrays”). Detailed
information about the experimental and analytical
strategies for quantifying these cellular traits are provided
in the “Methods” section. Additional file 1: Figures S1, S2,
and S3 give an overview of the data quality assessment of
the gene expression and DNA methylation data sets. All
individuals were further profiled for DNA sequence
variation using whole-genome sequencing to allow for
cell type-dependent, quantitative assessment of the
genetic and epigenetic determinants of transcriptional
variance [24].
In this study, we exploited this resource, selecting all
125 donors for whom matched gene expression and
DNA methylation data sets were available across the
three immune cell types. The key analytical advance of
the work presented here concerns the measurement and
interpretation of differential variability. That is, the iden-
tification of loci at which gene expression and DNA
methylation levels show significantly greater variation
within one cell type compared to the other cell types.
An overview of the study design and analytical concept
is provided in Fig. 1a.
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Genome-wide patterns of differential gene expression
variability across immune cell types
We first assessed inter-individual expression variability
of 11,980 protein-coding, autosomal genes that showed
robust expression in monocytes, neutrophils, and T
cells (“Methods”). We applied an improved analytical
approach for the assessment of differential variability
(“Methods”), taking into account the strong negative
correlation between mean gene expression levels and
expression variability (Additional file 1: Figure S4).
Figure 1b gives an overview of the number of identi-
fied HVGs that are cell type-specific, shared between
two of the studied immune cell types, or common to all
three. Neutrophils were found to have the largest num-
ber of HVGs overall (n = 1862), as well as of cell type-
specific HVGs (n = 1163). In contrast, we found only a
small number of cell type-specific HVGs in monocytes
and T cells (n = 14 and 3, respectively). In addition, we
identified 271 genes that were highly variable across all
three immune cell types using a rank-based approach
Fig. 1 Differential variability of gene expression and DNA methylation across three immune cell types. a Study design and analytical approach.
Hypervariable genes and CpGs were identified using a combined statistical approach at stringent significance thresholds, i.e., Benjamini–
Hochberg-corrected P < 0.05 and gene expression or DNA methylation variability measurement (EV or MV) difference ≥10% relative to the
observed range. b The number of statistically significant hypervariable genes (HVGs) that are cell type-specific, shared between two of the studied
immune cell types, or common to all three. c Scatter plot of the EV values of 6138 genes assessed in our data set versus the replication set. We
found good concordance between the two independent cohorts, despite the application of different analytical platforms (Pearson’s r = 0.48, P < 2.2 ×
10−16). d Ranking of all 11,980 protein-coding genes analyzed in our study according to EV values (i.e., from high to low EV values). We highlight the
100 genes that showed the highest and lowest EV values in the independent replication data set in red and blue, respectively. e The number
of hypervariable CpG positions (HVPs). Abbreviations: M monocytes, N neutrophils, T naïve T cells
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(“Methods”). Mature neutrophils (as profiled here) show
low proliferative capacity and reduced transcriptional and
translational activity [25, 26]. The latter could potentially
impede comparable assessment of differential variability if
the relationship between variability and mean expres-
sion levels was not taken into account. Thus, using our
analytical approach, we assessed and confirmed that
overall reduced gene expression levels did not technic-
ally confound the observed increased variability of gene
expression levels in neutrophils (Additional file 1:
Figure S4).
We then aimed to replicate the detected HVG levels
in an independent sample cohort. We retrieved a gene
expression data set generated using Illumina Human
HT-12 v4 Expression BeadChips consisting of CD16+
neutrophils derived from 101 healthy individuals; these
donors were, on average, 34 years of age (range 19–66
years) and 50% were male [27]. Of the 11,023 gene
probes assessed on the array platform, 6138 could be
assigned to a corresponding gene identifier in our data
set. First, we ranked all 11,980 genes analyzed in our
study according to gene expression variability (EV)
values from high to low. Then, we assessed the position
of the top 100 genes with highest and lowest EV values
from the independent validation data in this ranking to
confirm that the variability patterns are consistent be-
tween the two data sets. Neutrophil-specific HVGs mea-
sured using RNA-seq were also found to be hypervariable
using expression arrays in the independent cohort of
healthy individuals (Fig. 1c, d).
In summary, we devised and assessed a novel
method for the identification of differential gene ex-
pression variability. Overall, we found strongly in-
creased variability of gene expression in neutrophils
compared to monocytes and T cells and replicated the
detected neutrophil-specific HVG patterns in an exter-
nal cohort.
Biological significance of differentially variable genes
across immune cell types
Next, we explored the characteristics of the identified
HVGs. We performed ontology enrichment analysis of
gene sets using the GOseq algorithm [28]. This method
takes into account the effect of selection bias in RNA-
seq data that can arise due to gene length differences
[28]. Additional files 2 and 3 summarize the annotation
data of all identified HVGs and observed gene ontology
enrichment patterns, respectively.
Genes showing expression hypervariability across all
three cell types were enriched in biological processes
related to chemotaxis, migration, and exocytosis
(Additional file 3). For neutrophil-specific HVGs, we
found gene ontology enrichment in oxidoreductase activ-
ity and cellular processes related to virus response and
parasitism (Additional file 3). Notable genes among those
with hypervariable expression values were CD9 (Fig. 2a),
CAPN2 (Fig. 2b), and FYN (Fig. 2c). CD9 showed
increased variability across all three cell types. The gene
encodes the CD9 antigen, a member of the tetraspanin
family. It functions as cell surface protein that forms
complexes with integrins to modulate cell adhesion and
migration and mediate signal transduction [29, 30]. The
neutrophil-specific HVGs CAPN2 and FYN encode a
calcium-activated neutral protease involved in neutro-
phil chemotaxis [31] and a tyrosine-protein kinase
implicated in intracellular signal transduction [32],
respectively.
Taken together, functional enrichment of HVG sets
revealed that many of the identified HVGs are involved
in mediating immune-related processes. This suggests
that neutrophils exhibit specific gene loci that are highly
adaptable to external cues.
Determinants of inter-individual cell type-specific gene
expression variability
Following the discovery and characterization of genes
that present hypervariable expression levels between in-
dividuals, we next aimed to delineate potential sources
of heterogeneity that can be associated with differences
between individuals. We hypothesized that these sources
mainly relate to genetic variation, age, sex, and lifestyle
factors.
First, we determined the subset of cell type-specific
HVGs that correlated with genetic variants. We re-
trieved gene sets with a local (cis) genetic component
designated by expression quantitative trait locus (eQTL)
and variance decomposition analyses, as described in the
BLUEPRINT Human Variation Panel (Additional file 1:
Figure S5a). In neutrophils, we found that 638 of the
1163 cell-specific HVGs (55%) associate with cis genetic
variants (Additional file 2), at least partly explaining the
observed gene expression variability. These data are con-
sistent with previous reports, highlighting the role of
genetic variants in mediating transcriptional variance
[33–35].
Second, we correlated cell type-specific HVGs with vari-
ous quantitative traits measured in individual donors:
demographic information (age, body mass index, and alco-
hol consumption); cellular parameters as assessed by a
Sysmex hematology analyzer (e.g., cell count and size);
and season (i.e., minimum/maximum temperature and
daylight hours of the day on which blood was drawn). The
results of this analysis are provided in Additional files 2
and 4. In neutrophils, we identified 49 HVGs that show
significant association with at least one of the measured
traits (Fig. 2d). For example, we found NFX1, a nuclear
transcription factor that regulates HLA-DRA gene tran-
scription [36], to associate with neutrophil granularity
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(Fig. 2e). An increase in neutrophil granularity can be re-
flective of a potential infection; this parameter is routinely
monitored in a clinical setting. FYN gene levels (reported
above) were negatively correlated with neutrophil percent-
age (Fig. 2f).
Third, we investigated whether sex was an important
source of inter-individual (autosomal) gene expression
variability. We found only two of the 1163 neutrophil-
specific HVGs, SEPT4 and TMEM63C, to be differen-
tially expressed between sexes (Additional file 1: Figure
S6a), and high expression variability was observed for
both sexes in these genes. However, in neutrophils we
identified a surprisingly large number of sex-specific dif-
ferentially expressed genes of small effect size, which
corresponded to important immune cell functions. We
present a detailed analysis of these genes in the “Sex-
specific differential gene expression across immune cell
types” section.
In conclusion, we found that genetic makeup is an im-
portant determinant of transcriptional variability. Donor
demographic and lifestyle factors also contributed to-
wards transcriptional variability.
Fig. 2 Characterization of cell type-specific hypervariable genes. a–c Increased expression variability of the genes CD9, CAPN2, and FYN across
three immune cell types. For each cell type, data points represent the expression values of the indicated gene in one individual. Cell types marked
by an arrowhead were found to show significantly increased variability compared to the other two cell types. While CD9 was found to be hypervariable
in all three cell types, CAPN2 and FYN show increased variability only in neutrophils, if contrasted to monocytes and T cells. d Heatmap
of Spearman’s correlation coefficients showing neutrophil-specific HVGs that associated with various donor-specific quantitative traits.
A total of 49 genes with increased inter-individual variability showed a significant association with at least one of the measured traits
(Benjamini–Hochberg-corrected P < 0.05, Spearman’s rank correlation). e NFX1 gene expression levels versus neutrophil granularity. f FYN gene
expression levels versus neutrophil percentage. BMI body mass index
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Neutrophil-specific hypervariable genes not mediated by
cis genetic effects
Next, we studied in detail the subset of neutrophil-
specific genes that showed hypervariable expression but
did not associate with local genetic variants (n = 525).
Although some of these genes could be mediated by dis-
tal (trans) genetic factors not detected in the BLUE-
PRINT Human Variation Panel, it is conceivable that
expression heterogeneity of this gene set was primarily
due to external triggers or stochastic fluctuations.
We generated a correlation matrix of expression
levels of the 525 HVGs and identified clusters of corre-
lated genes that may act in concert or be co-regulated.
The identified co-expression network contained 259
connected genes and consisted of three distinct gene
modules (Fig. 3). We inferred biological functions corre-
sponding to the three gene modules. All modules were
highly enriched for genes with important immune-related
functions.
The first and largest gene module (n = 105 genes,
green in Fig. 3) showed enrichment for inclusion body,
receptor signaling, and immune response activation. The
second module (n = 78 genes, yellow) was enriched in
biological processes related to RNA processing and
chaperone binding. The third gene module (n = 33
genes, red), contained many genes with particularly high
variation in their expression patterns. RSAD2, an
interferon-inducible antiviral protein, showed the highest
variability among many other interferon-inducible genes
present in module three. These genes are essential in
Fig. 3 Gene network and pathway analysis of neutrophil-specific HVGs not mediated by cis genetic effects. Co-expression network of
neutrophil-specific HVGs that did not correlate with genetic variants in cis, as reported in the BLUEPRINT Human Variation Panel. We identified
three gene modules, shown in green, yellow, and red. These modules were highly enriched for important biological functions in immune cells
(Additional file 5). Nodes represent genes and edges represent correlations in these genes’ expression values. Node sizes are determined by
expression variability of the corresponding gene, with bigger nodes indicating higher EV values. Nodes colored in gray belong to several
smaller gene clusters connecting the three main clusters of the network
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innate immune response to viral infections [37]. Gene
ontology and pathway analyses of all genes in the net-
work module further showed a strong enrichment for
response to type I interferon and several viral disease
pathways, including influenza A, herpes simplex, and
hepatitis (Additional file 1: Figure S7). A detailed func-
tional annotation of all three network modules is pro-
vided in Additional file 5.
Sex-specific differential gene expression across immune
cell types
In our analysis, we only detected differences in mean gene
expression levels between male and female donors with log-
fold change ≥1, for 21 genes in neutrophils, two of which
were also found to be HVGs in neutrophils (Additional file
1: Figure S6a). Nonetheless, when no minimum log-fold
change criterion was applied, we found that sex-dependent
mean expression of autosomal genes (Additional file 1:
Figure S6b) was highly abundant in neutrophils (n = 3357
genes) compared to Tcells (n = 895) and monocytes (n = 64).
As many autoimmune diseases have a higher incidence
in females, and females show generally elevated immune
responses compared to males [38], we hypothesized that
genes with elevated gene expression levels in females
may account for the increased incidence rates. Indeed,
genes with higher mean expression levels in neutrophils
derived from females (n = 682) were enriched in immune
response and related pathways (Additional file 6). In
contrast, genes with increased mean expression in
male donors (n = 2675) were enriched in basic cellular
processes, such as RNA processing and translation
(Additional file 6). In addition, in male donors, genes
were strongly enriched in cellular compartments, such
as nuclear lumen (Additional file 6).
Genome-wide patterns of differential DNA methylation
variability across immune cell types
Following the analyses of differential gene expression vari-
ability, we then applied our improved analytical approach
to determine the inter-individual variability of DNA
methylation levels at 440,905 CpG sites (“Methods”).
Again, our method accounted for confounding effects due
to the correlation between mean and variability measure-
ments (Additional file 1: Figure S8).
Concordant with our findings for gene expression
variability (Fig. 1b), we found that neutrophils had
the largest number of hypervariable CpG positions
(HVPs) overall (n = 1053), as well as cell-specific
HVPs (n = 261). Neutrophils and monocytes shared a
considerable number of HVPs (n = 380) in contrast to
T cells (Fig. 1e). Finally, we identified 212 HVPs com-
mon to all three cell types. An overview of the num-
ber of HVPs is shown in Fig. 1e.
Following the discovery of HVPs, we examined
whether these sites were overrepresented at particular
gene elements and epigenomic features. To this end,
we focused on cell type-specific HVPs, correlating
their DNA methylation levels with distinct cellular
characteristics and molecular pathways. In Additional
file 7, we summarize the detailed annotation of all
HVPs across the three profiled immune cell types. In
neutrophils, we found that cell type-specific HVPs
were depleted at CpG islands, which typically occur
near transcription start sites (P = 6.37 × 10−19, hyper-
geometric test; Fig. 4a), and enriched at intergenic re-
gions (P = 0.03; Fig. 4b).
We hypothesized that cell type-specific HVPs
localize at distal gene regulatory elements such as en-
hancer sequences, of which many are known to be also
cell type-specific [39]. To test this hypothesis, we re-
trieved reference chromatin state maps of primary
human monocytes, neutrophils, and T cells from the
data repository provided by the BLUEPRINT Consor-
tium [40]. Chromatin states are defined as spatially co-
herent and biologically meaningful combinations of
multiple chromatin marks [41, 42]. A total of five
chromatin states were designated, which correspond
to functionally distinct genomic regions, namely active
promoters, enhancers, and regions related to tran-
scriptional elongation and polycomb-repression. In
addition, a “variable” chromatin state was defined
here, indicating frequent changes of local chromatin
structure across samples of the same cell type. Indeed,
neutrophil-specific HVPs were found to be strongly
enriched in the enhancer (P = 1.32 × 10−12, hypergeo-
metric test; Fig. 4c) and variable chromatin states (P =
3.81 × 10−8; Fig. 4c).
Biological significance of immune cell type-specific
hypervariable CpGs
To interpret the potential cellular and biological im-
plications of cell type-specific hypervariable CpGs, we
annotated the genes in close proximity to each CpG
using the Genomic Regions Enrichment of Annota-
tions Tool (GREAT) [43]. This tool is valuable in
assigning putative functions to sets of non-coding
genomic regions [43].
Overall, we found enrichment in gene ontology terms
attributed to genes close to HVPs in a cell type-
dependent context (Additional file 8). For example,
genes located near neutrophil-specific HVPs were
enriched in gene signatures related to acute Streptococ-
cus pneumoniae infection and cysteine synthase activity;
the latter molecular process is important to hold off in-
fections [44]. Consistent with established neutrophil
function, this suggests that the identified HVPs play a
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role in regulating the expression of neutrophil-specific
genes in response to infection.
In Fig. 4d, we provide an example of a neutrophil-
specific HVP at the promoter of the ITGB1BP1 gene, en-
coding the integrin beta 1 binding protein 1. Integrins are
essential cell adhesion proteins that induce intracellular
signaling pathways upon activation by matrix binding
[45, 46]. They function as signal transducers allowing
for rapid responses to cell surface signals [46]. Notably,
the highlighted HVP mapped to a variable chromatin
state at this locus, indicating that it influences local
chromatin dynamics upon an internal or external trig-
ger (Fig. 4d).
In conclusion, we show that cell type-specific HVPs
clustered in enhancer and dynamic chromatin states at
intergenic regions, suggesting they play a role in the
Fig. 4 Functional annotation of neutrophil-specific hypervariable CpG positions. a Enrichment of neutrophil-specific HVPs (n = 261) at genomic
features. We found neutrophil-specific HVPs to be depleted at CpG islands (P = 6.37 × 10−19, hypergeometric test). b Enrichment of neutrophil-
specific HVPs at gene elements. Neutrophil-specific HVPs were enriched at intergenic regions (P = 0.03). c Enrichment of neutrophil-specific HVPs
at distinct reference chromatin states in neutrophils. The HVPs were enriched at enhancer (P = 1.32 × 10−12) and “variable” (P = 3.81 × 10−8)
chromatin states. A variable chromatin state denotes a state that was observed in less than 80% of the biological replicates (n ≥ 5) within a
given cell type and indicates dynamic changes of local chromatin structure. d Regional plot of an exemplar neutrophil-specific HVP mapping
to the promoter of the ITGB1BP1 gene, encoding the integrin beta 1 binding protein 1. The statistically significant HVP is indicated with an
arrowhead. For each cell type, data points represent the DNA methylation β values (y-axis) at the indicated CpGs (x-axis) in one individual. For
each CpG site, we calculated the mean DNA methylation value (indicated with a larger data point). Every CpG site is annotated with regards
to genomic feature, gene element, and chromatin state. Abbreviations: M monocytes, N neutrophils, T naïve T cells, TSS transcription start site,
CGI CpG island, UTR untranslated region, prom promoter
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regulation of cell type-specific gene expression pro-
grams in response to environmental changes. Genes in
proximity to HVPs were enriched in gene sets relevant
to important immunological functions.
Determinants of inter-individual cell type-specific DNA
methylation variability
Subsequent to the identification and annotation of CpGs
with hypervariable DNA methylation levels, we explored
potential reasons for the discovered inter-individual
DNA methylation heterogeneity.
In agreement with our findings for gene expression
variability, we determined that a large proportion of cell
type-specific HVPs correlated with cis genetic variants
reported in the BLUEPRINT Human Variation Panel
(Additional file 1: Figure S5b). In neutrophils, we found
that 167 of the 261 cell type-specific HVPs (64%) asso-
ciated with DNA methylation quantitative trait loci
(Additional file 7). Our data further revealed that none
of the cell type-specific HVPs were differentially meth-
ylated between male and female donors. The complete
numerical results of all correlation analyses are pro-
vided in Additional file 9.
HVPs specific to monocytes showed frequent associ-
ation with seasonal effects, such as temperature and day-
light (n = 12/117 HVPs; Additional file 1: Figure S9).
This finding is consistent with recent analyses reporting
fluctuations of gene expression levels in monocytes de-
pending on the season and circadian rhythm [47]. Many
CD4+ T cell-specific HVPs particularly correlated with
donor age (n = 14/46 HVPs; Additional file 1: Figure S9),
in line with previous findings on age-related DNA
methylation changes in T cells [48, 49]. These alterations
are especially interesting in the context of immunose-
nescence, for which dysregulation in T-cell function is
thought to play a crucial role [50, 51]. Naïve CD4+ T
cells have further been reported to become progressively
longer-lived with increasing age [52], which possibly also
impacts their DNA methylation patterns.
Correlation of DNA methylation variability with
transcriptional output
DNA methylation at active gene elements can directly
control the regulation of gene expression. While meth-
ylated gene promoters usually lead to transcriptional
silencing, methylated gene bodies typically lead to tran-
scriptional activation [53]. We next aimed to probe this
paradigm in the context of gene expression and DNA
methylation variability.
We measured the correlation of DNA methylation
variability with transcriptional output at the level of sin-
gle genes. Specifically, we studied cell type-specific HVPs
that map to gene promoters and bodies, correlating their
DNA methylation level with the gene expression level in
the same individuals. At promoters, 30.1% (range 23.5–
33.3%) of HVPs showed a negative correlation with gene
expression (Fig. 5a), in support of the conventional role
of DNA methylation in gene repression. At gene bodies,
a small subset of HVPs (5.0%; range 0.0–10.8%) showed
a positive correlation with gene expression (Fig. 5b).
Additional file 10 gives a full account of these genes and
numeric results.
An example is provided in Fig. 5c, showing a monocyte-
specific HVP at the gene promoter of MSR1. At this CpG
site, DNA methylation levels were significantly correlated
with gene repression (Benjamini–Hochberg (BH)-cor-
rected P < 2.2 × 10−16, Spearman’s rank correlation).
MSR1, encoding the CD204 antigen, is involved in
endocytosis of modified low-density lipoproteins.
Relationship between DNA methylation variability and
gene expression variability
Finally, we examined global patterns of DNA methyla-
tion variability in relation to transcriptional variability.
In neutrophils, highly variable gene expression levels
were observed at promoters exhibiting highly variable
DNA methylation levels, and also at promoters showing
very stable DNA methylation levels (Fig. 5d). For DNA
methylation variability at gene bodies, this relationship
was weaker and showed a linear tendency (Fig. 5e). Im-
portantly, these global patterns were consistent across all
three immune cell types (Additional file 1: Figure S10).
To characterize these promoter regions further, we
counted the number of transcription factor binding mo-
tifs at these regions (“Methods”). We found an accumu-
lation of binding motifs at promoters presenting either
highly variable or very stable DNA methylation levels
(Fig. 5f; Additional file 1: Figure S8). Next, we explored
the properties of the 100 genes that showed both the
highest expression variability and the highest DNA
methylation variability at their promoters. We found
that of the 100 genes in each cell type, 66 were common
to all three cell types; in turn, ten of these 66 genes en-
code transcription factors. For example, in neutrophils
this included ELF1, a transcriptional regulator of genes
involved in immune response signaling pathways [54].
Neutrophil-specific HVGs were also enriched at genes
with promoter sequences that contain the consensus
binding motif of ELF1 (BH-corrected P = 1.2 × 10−5;
MSigDB analysis).
Taken together, these results provide evidence that
DNA methylation variability and gene expression vari-
ability could be mediated by the sequence-specific bind-
ing of transcription factors, such as ELF1 in neutrophils.
Future studies will be required to further investigate the
functional relevance of the observed correlation.
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Discussion
In this study, we investigated the transcriptional and epi-
genetic variability that enables immune cells to rapidly
adapt to environmental changes. To this end, we devised
a novel analytical strategy to assess the inter-individual
variability of gene expression and DNA methylation as a
measure of functional plasticity across three immune cell
types.
Our integrative analyses revealed two key insights.
Firstly, neutrophils exhibit substantially increased vari-
ability of both gene expression and DNA methylation
when directly compared to monocytes and T cells
(Additional files 2 and 7). Gene expression variability in
monocytes and T cells is either shared with neutrophils
or does not reach statistical significance in comparison
to neutrophils and/or the other cell type (Fig. 1b). We
hypothesized that neutrophils require higher gene ex-
pression variability in order to perform their unique
biological functions as first responders of the immune
system. Neutrophils have to readily react to changing
conditions, which is facilitated by highly variable gene
expression patterns. Functional enrichment and net-
work analyses characterizing the neutrophil-specific
hypervariability supported this hypothesis (Fig. 3;
Additional files 3, 5, 8; Additional file 1: Figure S7).
For example, genes with important functions in intra-
cellular signaling, cell adhesion, and motility showed
increased variability (Additional files 3 and 8). Such
variability is likely mediated or additionally influenced
by epigenetic mechanisms. Indeed, a subset of these
genes was found to be under sole epigenetic control,
such as RSAD2, a gene involved in interferon-
mediated immune response (Fig. 3). Notably, cell type-
specific differential DNA methylation variability was
also highest for neutrophils compared to the other cell
types (Fig. 1e).
Secondly, neutrophils display an increased number of
sex-specific gene expression differences compared to
Fig. 5 Relationship between DNA methylation and gene expression. a The proportion of cell type-specific HVPs that map to gene promoters and
are positively (red), negatively (blue), or not (white) associated with gene expression levels at Benjamini–Hochberg-corrected P < 0.05 (Spearman’s
rank correlation). We found that around one-third of these HVPs (30.1%; range 23.5–33.3%) are negatively correlated with gene expression. b
Same as panel a but for HVPs that map to gene bodies. c The negative correlation of MSR1 promoter DNA methylation with gene expression in
monocytes (r = −0.70, P < 2.2 × 10−16; Spearman’s rank correlation). d Correlation between DNA methylation variability (MV) and gene expression
variability at gene promoters in neutrophils. First, gene-wise MV values were calculated. Then, the values were ordered from low to high MV value,
grouped together in bins of 100 genes, and plotted against the EV values, maintaining the ordering by MV values. This binning strategy was
applied to reduce the complexity of the data. HVPs at gene promoters were defined as CpG sites annotated to TSS1500, TSS200, 5′ UTR, and first
exon, according to the Illumina 450 K array annotation manifest. Darker data points indicate the subset of bins that is further discussed in the
“Results” section. e Same as panel d but for HVPs that map to gene bodies. HVPs at gene bodies were defined as CpGs annotated to body and
3′ UTR, according to the 450 K array annotation manifest. f The number of consensus transcription factor (TF) binding motifs at promoter
regions versus MV values in neutrophils. Promoter regions were defined as ±500 bp around the transcription start site. Darker data points
indicate the subset of bins that is further discussed in the “Results” section
Ecker et al. Genome Biology  (2017) 18:18 Page 10 of 17
monocytes and T cells (Additional file 1: Figure S6b).
Genes with elevated expression levels in neutrophils de-
rived from females were associated with immune-related
processes (Additional file 6). These results suggest a po-
tential mechanistic basis for the higher incidence rates
of many autoimmune diseases in females, such as mul-
tiple sclerosis, rheumatoid arthritis, and autoimmune
hepatitis.
We acknowledge that our study has limitations: The
data underlying the BLUEPRINT Human Variation
Panel was generated in different laboratories. While the
study design using systematic, paired analyses across cell
types and individuals, and stringent quality control and
statistical approaches reduced possible batch effects
(Additional file 1: Figure S1), residual technical effects
may still be present. Heterogeneity may also be partly
explained by differing stages and rates of cell activation
and cell death during experimental processing, as well as
unaccounted environmental effects such as circadian
rhythm, diet, physical activity, and psychological stress,
which could affect one cell type more than the other(s).
Differences in the proportions of cellular subpopula-
tions may contribute to overall elevated variability
between individuals. We have thus assessed the expres-
sion profiles of a number of genes that identify distinct
cellular subpopulations of neutrophils [55]: CXCR4,
CD63, CD62L (also known as SELL), and CD49 (also
known as ITGA4). We did not observe inter-individual
gene expression differences of surface markers corre-
sponding to known neutrophil subpopulations, with the
exception of CD49 (Additional file 1: Figure S11). We
note that CD49 gene expression levels did not correlate
with neutrophil granularity (BH-corrected P = 0.89,
Spearman’s rank correlation). These data suggest that
variation in neutrophil subpopulations is unlikely to be
a main determinant of increased inter-individual vari-
ability. Future studies are required to corroborate these
results and to determine whether uncharacterized cel-
lular subpopulations may contribute to the observed
heterogeneity.
Novel transcriptome and epigenome profiling (e.g.,
scM&T-seq [56] and scWGBS [57]) and computational
tools (e.g., single-cell latent variable models (scLVM)
[58]) are now available to allow for measurements of
gene expression and DNA methylation at the level of
single cells. Such approaches have already been success-
fully used to quantify cell-to-cell expression variation
and to identify otherwise undetected subpopulations of
primary human immune cells [59–61]. Multi-omics sin-
gle cell assays that capture not only transcriptomes and
epigenomes but also proteomes and metabolomes will
be used for the comprehensive functional annotation of
single cells [62]. The application of these approaches will
facilitate the dissection of cellular subpopulations and
reveal valuable additional information about the func-
tional heterogeneity of neutrophils.
In summary, we provide a novel analytical strategy and
comprehensive resource for future research into the
plasticity of immune cells. For our analyses, we exploited
the unique resource provided by the BLUEPRINT
Human Variation Panel, enabling us to conduct the most
comprehensive study of differential variability in primary
cell types to date. We have prepared all data sets gener-
ated in this study as an easily accessible and freely avail-
able online resource, comprising all results that showed
statistical significance (n = 3378) [63]. The portal enables
the research community to further characterize the hy-
pervariable gene–phenotype associations (Additional
files 4 and 9) using experimental approaches. For ex-
ample, gene expression and DNA methylation hyper-
variability could be correlated to pathophysiological
triggers of immune responses, such as interferon-γ and
lipopolysaccharide [64]. These future studies will help
elucidate how increased variability of gene expression and
DNA methylation relate to functional diversity and effect-
ive adaptability during homeostatic and potentially patho-
genic immune processes.
Conclusions
We found that neutrophils show increased variability in
both their gene expression and DNA methylation pat-
terns compared to monocytes and T cells. Our data
suggest that increased variability in neutrophils may
lead to cellular plasticity, enabling rapid adaptation to
new or changing environments such as inflammation
and pathogen intrusion. A detailed molecular under-
standing of the role of cellular heterogeneity in the hu-
man immune system is crucial to specifically target a
pathogenic cellular subset without compromising im-
munity, ultimately advancing therapeutic design and
treatment strategies in hematopoietic and immuno-
logical diseases.
Methods
Sample collection and isolation of cell subsets
As part of the BLUEPRINT Human Variation Panel, a
total of 200 healthy blood donors were recruited from
the NIHR Cambridge BioResource [65]. Donors were
on average 55 years of age (range 20–75 years) and 46%
of donors were male. For all donors, a unit of whole
blood (475 ml) was collected in 3.2% sodium citrate, of
which an aliquot was collected in EDTA for genomic
DNA purification and a full blood count using a Sys-
mex hematology analyzer. Blood was processed within
4 h of collection. We purified CD14+CD16− monocytes,
CD66b+CD16+ neutrophils, and naïve CD4+CD45RA+
T cells using a multi-step purification strategy. In brief,
whole blood was diluted 1:1 in a buffer of Dulbecco’s
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phosphate-buffered saline (PBS, Sigma) containing
13 mM of sodium citrate tribasic dehydrate (Sigma)
and 0.2% human serum albumin (HSA, PAA), and then
separated using an isotonic Percoll gradient of 1.078 g/
ml (Fisher Scientific). Peripheral blood mononuclear
cells were collected, washed twice with buffer, diluted
to 25 million cells/ml, and separated into a monocyte-
rich layer and a lymphocyte-rich layer using a Percoll
gradient of 1.066 g/ml. Cells from each layer were
washed with PBS containing 13 mM of sodium citrate
and 0.2% HSA, and subsets purified using a strategy
based on magnetic beads conjugated to highly specific
antibodies. First, CD16+ cells were depleted from the
monocyte-rich layer using CD16 MicroBeads (Miltenyi)
according to the manufacturer’s instructions. Cells were
washed in PBS (13 mM of sodium citrate and 0.2% HSA)
and CD14+ cells were positively selected using CD14
MicroBeads (Miltenyi). Next, CD4+ naïve T cells were
negatively selected using an EasySep Human Naive CD4+
T Cell Enrichment Kit (StemCell) according to the manu-
facturer’s instructions. Finally, the dense layer of cells from
the 1.078 g/ml Percoll separation was lysed twice using an
ammonium chloride buffer to remove erythrocytes. The
resulting cells (including neutrophils and eosinophils)
were washed, and neutrophils positively selected using
CD16 MicroBeads (Miltenyi) following the manufacturer’s
instructions. The purity of each cell preparation was
assessed by multi-color fluorescence-activated cell sort-
ing (FACS). The following antibodies were used: CD14
(M4P9, BD Biosciences) and CD16 (B73.1/Leu-11c, BD
Biosciences) for monocytes; CD16 (VEP13, MACS,
Miltenyi) and CD66b (BIRMA 17C, IBGRL-NHS) for
neutrophils; and CD4 (RPA-T4, BD) and CD45RA
(HI100, BD) for T cells. Purity was on average 95% for
monocytes, 98% for neutrophils, and 93% for T cells.
Purified cell aliquots were pelleted, stored at −80 °C,
and transported to the processing institutes. Further
details about the experimental protocols and quality
control assessments are provided by the BLUEPRINT
Human Variation Panel.
RNA-sequencing assay and data preprocessing
RNA-seq sample preparation and library creation were
performed for monocytes and neutrophils at the Max
Planck Institute for Molecular Genetics (Germany), and
for T cells at McGill University (Quebec, Canada). Puri-
fied cell aliquots were lysed and RNA extracted using
TRIZOL reagent (Life Technologies) following the man-
ufacturer’s protocol. Sequencing libraries were prepared
using a TruSeq Stranded Total RNA Kit with Ribo-Zero
Gold (Illumina). Adapter-ligated libraries were amplified
and indexed via PCR. Libraries were sequenced using
100-bp single-end reads for monocytes and neutrophils
and paired-end reads for T cells. Reads from each
RNA-seq library were assessed for duplication rate and
gene coverage using FastQC [66]. Then, PCR and se-
quencing adapters were trimmed using Trim Galore.
Trimmed reads were aligned to the GRCh37 reference
genome using STAR [67]. We used GENCODE v15 to
define the annotated transcriptome. Read counts of
genes and exons were scaled to adjust for differences in
total library size using DESeq2 [68]. We adjusted for
batch effects related to sequencing center using an em-
pirical Bayesian method, ComBat [69]. Batch effects
were assessed using cross-over samples, i.e., identical
samples of each cell type per sample batch that were
sent to the reciprocal center not processing the cell
type. Visual inspection of the results by multidimen-
sional scaling showed a successful reduction of batch
effects following the application of ComBat (Additional
file 1: Figure S1a). In addition, we calculated the correl-
ation coefficients of all cross-over samples after batch
effect correction. We obtained a mean correlation coef-
ficient of r = 0.96 (n = 15 cross-over samples), indicating
data consistency across the processing centers. An
overview of the RNA-seq data quality assessment is
provided in Additional file 1: Figure S2.
Quantification of gene expression
Analyses on RNA-seq data were performed on exon-
based read counts per gene. We omitted all genes not
expressed in at least 50% of all samples in each of the
three cell types, leaving only genes that were robustly
expressed in all three cell types. In addition, we in-
cluded only protein-coding genes, resulting in a final
set of 11,980 genes. RNA-seq read counts were con-
verted into expression log counts by applying the for-
mula log2(x + 1).
Illumina Infinium HumanMethylation450 assay and data
preprocessing
For monocytes and neutrophils, cell lysis and DNA ex-
traction were performed at the University of Cambridge
(UK), followed by bisulfite conversion and DNA methy-
lation profiling at University College London (UK). T
cells were processed at McGill University (Quebec,
Canada). DNA methylation levels were measured using
Infinium HumanMethylation450 assays (Illumina) ac-
cording to the manufacturer’s protocol. All 450 K array
data preprocessing steps were carried out using estab-
lished analytical methods incorporated in the R package
minfi [70]. First, we performed background correction
and dye-bias normalization using NOOB (normal-expo-
nential convolution using out-of-band probes). The
method estimates the background mean intensity using
the over 135,000 out-of-band control probes, which pro-
vide signals in the opposite fluorescent channel from the
probe design. NOOB effectively adjusts for differences in
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background distribution and average intensities in the
fluorescent channels between samples run on different
arrays [71]. Then, we applied SWAN (subset-quantile
within array normalization), a within array normalization
method that reduces the differences in β-value distribu-
tion between Infinium I and II probe types [72]. Next,
we filtered out probes based on the following criteria:
(1) low detection P value (P ≥ 0.01) in at least one sam-
ple; (2) bead count of less than three in at least 5% of
samples; (3) mapping to sex chromosomes; (4) ambigu-
ous genomic locations [73]; (5) non-CG probes; and (6)
containing SNPs (MAF ≥ 0.05) within 2 bp of the probed
CG. Finally, we adjusted for batch effects due to process-
ing center and analysis date using an empirical Bayesian
framework [69], as implemented in the ComBat function
of the R package SVA [74]. Multidimensional scaling
analyses following the application of ComBat revealed
no apparent batch effects (Additional file 1: Figure S1b).
After batch effect correction, the mean correlation coef-
ficient across cross-over samples was r = 0.99 (n = 9 sam-
ples), confirming data consistency across processing
centers. An assessment of the DNA methylation data
quality is shown in Additional file 1: Figure S3. In paral-
lel, we performed singular value decomposition (SVD) of
the DNA methylation data, which determined the com-
ponents of variation (Additional file 1: Figure S3c).
Quantification of DNA methylation
The final data set that passed quality control consisted
of 440,905 CpG sites. DNA methylation values were rep-
resented as either M values or β values. The methylation
M value is the log2 ratio of the intensities of the methyl-
ated probe versus the unmethylated probe on the 450 K
array, while the β value is the ratio of the methylated
probe intensity and the overall intensity. All analyses of
DNA methylation data were performed using M values.
Due to their easier interpretability (i.e., 0–100% DNA
methylation), β values were used for the visualization of
DNA methylation data in most figures.
Analysis of differential variability
To assess differential variability across the three cell
types, we applied a combined statistical approach based
on DiffVar [75], which is embedded in the framework of
limma [76, 77]. DiffVar calculates the median absolute
deviation (MAD) from the group mean of expression
levels of a particular gene, or DNA methylation at a
given CpG site, across all individuals for two conditions,
e.g., two distinct cell types. Then, a moderated t-test is
used to test for a significant increase or decrease in
MAD value between the two conditions. However, we
found that the MAD variability measurement employed
by DiffVar is correlated with mean levels (Additional file
1: Figures S4 and S8), which could potentially confound
the assessment of variability. Therefore, we included an
additional measurement of variability that corrects for
the dependency of variability measurements on the
mean [8], here referred to as EV (gene expression vari-
ability value) and MV (DNA methylation variability
value). The corresponding algorithm models variance as
a function of the mean and then calculates the ratio of
the observed variance to expected variance in order to
get a variability measurement independent of the mean.
Differential variability was tested in three group-wise
comparisons. Statistical significance was defined as BH-
corrected [78] P < 0.05 and EV/MV difference ≥10% rela-
tive to the observed range of EV/MV values. For each
cell type, both contrasts in which the cell type is in-
volved were considered to define statistically significant
differential variability. For example, for a gene to be a
neutrophil-specific HVG, it must show significantly in-
creased variability in both the comparison versus mono-
cytes and versus T cells. For a gene to be classified as
hypervariable across two cell types (shared hypervariabil-
ity), it must exhibit significantly increased variability in
the two corresponding cell types but low variability in
the third. Thus, no gene can appear in more than one
list. The statistical tests were performed in a paired fash-
ion, taking into account that all three cell types were de-
rived from the same individuals. This procedure corrects
for potential differences related to individuals and sam-
ple processing.
Analysis of variability common to all three cell types
To identify HVGs common to all three cell types, we ap-
plied a rank-based approach. We ordered both MAD
and EV values of all genes in the three cell types from
high to low variability and then took the top n genes
with the highest variability across all three cell types,
where n corresponds to the mean number of results ob-
tained for the gene lists of differential variability. Specif-
ically, n = 271 for gene expression variability and n = 212
for DNA methylation variability.
Gene set enrichment analyses
For HVGs, we applied GOseq using the default parameters
and set ‘use_genes_without_cat’ = FALSE, thus ignoring
genes without an annotated category for the calculation of
P values [28]. With regards to HVPs, we analyzed the bio-
logical functions of flanking genes with GREAT [43] using
the standard parameters: association rule = basal + exten-
sion (constitutive 5 kb upstream, 1 kb downstream, up to
1 Mb extension); curated regulatory domains = included.
In both analyses, we used the set of analyzed features as
background, and the cutoff for statistical significance was
set at BH-corrected P < 0.25.
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Gene co-expression network and pathway analysis
For neutrophil-specific HVGs not associated with cis
genetic variants in the BLUEPRINT Human Variation
Panel, we first constructed a co-regulation network by
calculating gene expression correlations. The threshold
of gene correlations was set at Pearson’s r > 0.6. Uncon-
nected genes were removed. The resulting correlation
network was then further analyzed using Cytoscape [79].
Clusters were identified by the agglomerative clustering
method FAG-EC [80] of the ClusterViz plugin. Enrich-
ment analyses of resulting gene clusters were performed
using clueGO [81], setting the Kappa score to 0.4 and
the cutoff for statistical significance at BH-corrected
P < 0.05. All networks were visualized using Gephi [82].
Correlation analyses
Associations between both gene expression and DNA
methylation levels with donor-specific quantitative traits,
cellular parameters, as well as weather and seasonal ef-
fects were assessed by calculating Spearman’s rank cor-
relation coefficients (rho) and their corresponding P
values. Results were considered statistically significant at
BH-corrected P < 0.05. This threshold was also used for
the correlation analyses between DNA methylation and
gene expression data.
Analyses of seasonal effects
We downloaded historical raw weather data for the
minimum and maximum daily temperature in London
Heathrow (UK) for the period of data collection from
the National Climatic Data Centre (USA) [83]. We ap-
plied linear interpolation to account for missing values.
Additionally, we downloaded daylight hours for London
[84]. The obtained data were then correlated with gene
expression and DNA methylation values corresponding
to the date of blood donation using Spearman’s rank
correlation coefficient (see details above).
Analyses of sex-specific differential gene expression
In each cell type, mean gene expression and DNA
methylation differences between male and female donors
were identified using limma [76, 77]. A moderated t-test
was performed and statistical significance defined as
BH-corrected P < 0.05 and log-fold change ≥1. Results
could be driven by differences in menopause status be-
tween female donors. Therefore, we performed the same
analysis on only the subset of donors who are younger
than 50 years and obtained very similar results com-
pared to the complete donor group.
Functional annotation of hypervariable CpGs
For the enrichment analyses with regards to gene ele-
ments and epigenomic features, we used the annota-
tion provided by the Illumina 450 K array manifest.
Enrichment was assessed by repeated random sam-
pling (n = 1000) using all probes that passed quality
control (n = 440,905), as previously described [85].
Transcription factor motifs analysis at gene promoter
regions
Consensus transcription factor binding motifs were re-
trieved from the database “JASPAR_CORE_2016_vertebra-
tes.meme” [86]. Using FIMO [87], we scanned for
transcription factor binding motifs (P < 1 × 10−5) at pro-
moter regions, defined as ±500 bp around the transcription
start site of genes listed in the reference gene set
“UCSC.hg19.knownGene”.
Programming language
If not indicated otherwise, analyses were performed
using R v3 (R Development Core Team, 2008) and Bio-
conductor [88].
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